To determine the utility of adding oral nonabsorbable antibiotics to the bowel prep prior to elective colon surgery. Summary Background Data: Bowel preparation prior to colectomy remains controversial. We hypothesized that mechanical bowel preparation with oral antibiotics (compared with without) was associated with lower rates of surgical site infection (SSI). Methods: Twenty-four Michigan hospitals participated in the Michigan Surgical Quality Collaborative-Colectomy Best Practices Project. Standard perioperative data, bowel preparation process measures, and Clostridium difficile colitis outcomes were prospectively collected. Among patients receiving mechanical bowel preparation, a logistic regression model generated a propensity score that allowed us to match cases differing only in whether or not they had received oral antibiotics. Results: Overall, 2011 elective colectomies were performed over 16 months. Mechanical bowel prep without oral antibiotics was administered to 49.6% of patients, whereas 36.4% received a mechanical prep and oral antibiotics. Propensity analysis created 370 paired cases (differing only in receiving oral antibiotics). Patients receiving oral antibiotics were less likely to have any SSI (4.5% vs. 11.8%, P ϭ 0.0001), to have an organ space infection (1.8% vs. 4.2%, P ϭ 0.044) and to have a superficial SSI (2.6% vs. 7.6%, P ϭ 0.001). Patients receiving bowel prep with oral antibiotics were also less likely to have a prolonged ileus (3.9% vs. 8.6%, P ϭ 0.011) and had similar rates of C. difficile colitis (1.3% vs. 1.8%, P ϭ 0.58).
F or over 50 years, surgeons have debated the optimal preparation of the patient for elective colon surgery. The primary focus of this debate has centered on the use of mechanical bowel preparation, and particularly whether or not oral nonabsorbable antibiotics should be a part of the standard bowel preparation regimen. [1] [2] [3] [4] [5] It seemed intuitive to surgeons that reducing the bacterial load of stool in the colon prior to surgery would reduce the incidence of infectious complications. But in later years, as the administration of parenteral antibiotics at the time of surgery became routine, some questioned whether oral antibiotics were necessary. More recently enthusiasm for bowel preparation itself has diminished, oral antibiotics or not. Randomized controlled trials (RCTs) isolating bowel preparation as a variable (bowel preparation yes or no) have failed to show benefit to the bowel preparation. 6 -11 But the RCTs in this area, and the meta-analyses that have studied them, have failed to consider whether or not oral antibiotics were a part of the bowel preparation strategy. 6,9 -13 This is an important omission; one relatively recent RCT demonstrated an important beneficial effect on wound infection rates if oral antibiotics had been administered with mechanical preparation, even in this modern era, in which all patients routinely receive potent parenteral antibiotics. 14, 15 As was found in much earlier studies, administration of oral nonabsorbable antibiotics was associated with a reduced bacterial load in the stool, colonic mucosa, and subcutaneous fat at the site of incision, suggesting a cause and effect relationship with infectious complications. 1,2,4,5,16 -19 So far, no RCT has compared a strategy of parenteral antibiotic only, without any kind of mechanical bowel prep, to one involving parenteral antibiotics and mechanical bowel prep followed by the administration of oral nonabsorbable antibiotics. In the absence of such a trial, we have encouraged the surgical community to avoid a rush to judgment. 20 There may still be an important place for a bowel preparation approach in modern colonic surgery.
In analyzing the practice of colonic surgery in Michigan, using the structure of the Michigan Surgical Quality Collaborative (MSQC), we have come across what is a natural and empirical experiment regarding the question of oral antibiotics. Although most of surgeons in our state routinely do prescribe mechanical preparation prior to surgery, approximately half do not add oral nonabsorbable antibiotics to the preparation. To seize on this opportunity for analysis, we used a propensity matching approach to adjust for potential differences in patient characteristics and selection bias, and we used a very narrowly defined case selection approach to minimize differences in case mix. We then analyzed the 2 groups with regard to a variety of postoperative outcomes routinely measured by the ACS-NSQIP, and also with regard to several colon-specific outcome variables which we developed locally, and which are not a part of the ACS-NSQIP. Because some surgeons have informally voiced a concern that the use of oral nonabsorbable antibiotics might predispose to postoperative Clostridium difficile (C. difficile) colitis, we were particularly careful to define and measure this outcome in the 2 groups. 21, 22 
METHODS

The MSQC Colectomy Best Practices Study
The MSQC represents a partnership between 2 entities: Blue Cross and Blue Shield of Michigan/The Blue Care Network (BCBSM/BCN) and 34 Michigan hospitals. 23, 24 BCBSM/BCN has funded hospital participation in the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) for participating hospitals. The MSQC uses the basic data platform of the ACS-NSQIP to standardize data collection and outcomes and has also developed new process and outcome measures which pertain specifically to the colectomy procedure.
All MSQC hospitals (N ϭ 34) were offered the opportunity to participate, and 24 centers agreed. Cases selected for study were open segmental colectomy (44204), laparoscopic segmental colectomy (44140), ileocolic resection (44205), and laparoscopic ileocolic resection (44160). Participating centers captured defined colectomy cases when they fell within the ACS-NSQIP sampling framework, and were offered the option of adding all additional numbers of these same case types outside the ACS-NSQIP sampling methodology if workload allowed. 25 All standard ACS-NSQIP preoperative, operative, and postoperative variables were collected. Additional data was collected on the type of bowel preparation, diabetic management, venous thromboembolism prophylaxis, surgical site prevention practices (ie, normothermia and antibiotic dosing), operative techniques, the incidence of C. difficile colitis, anastomotic leak, ileus, ureteral injury, and need for splenectomy.
Study Population
Over the study period (August 2007-April 2009) data was entered on 2011 colectomy operations (open or laparoscopic segmental or ileocolic resection). Emergent colectomy was completed on 263 patients, and these patients were eliminated from all analysis. This left 1748 patients who underwent an eligible colon operation over the study period. Further, 195 patients (11.3%) did not receive any bowel preparation prior to elective colon surgery. These patients were also eliminated from the adjusted and matched analysis.
Data Analysis
Overall, 1553 patients received a bowel preparation prior to elective colon surgery. Differences among the demographic and clinical characteristics of the 2 study groups (no oral antibiotic and oral antibiotic at the time of bowel preparation) were assessed using simple univariate analysis. Significant differences were noted. To manage these differences and concerns regarding selection bias (patient selected to receive or not to receive oral antibiotics), we performed a propensity matched cohort analysis.
Multiple regression analysis was used to impute data for missing laboratory values for the analysis, as previously described. 26 Regression models were developed to predict missing laboratory values from existing laboratory values. Equations were developed for each hospital and month to adjust for seasonality and differences in laboratory technique.
Propensity score matching was used to adjust for factors statistically associated with receiving preoperative nonabsorbable antibiotics as part of the bowel prep. The propensity score is the probability of receiving an oral antibiotic, conditional on both preoperative and intraoperative factors. The propensity score was calculated using a standard multivariate logistic regression analysis, the primary outcome measure being the addition of oral antibiotics at the time of bowel preparation. Covariates in the logistic regression model included the following preoperative variables: blood urea nitrogen, creatinine, bilirubin, SGOT, white blood cell count, alkaline phosphatase, platelet count, prothrombin time, PTT, albumin, race, age, sepsis, functional status, cancer diagnosis, chronic obstructive pulmonary disease, congestive heart failure, hemiparesis, previous stroke, steroid use, recent weight loss, bleeding diathesis, coronary artery disease, alcohol use, peripheral vascular disease, preoperative dyspnea, preoperative smoking status, case relative value units (measure of case complexity), gender, diabetes status, compliance with bowel preparation, and insurance status. In addition, the logistic regression model included the following perioperative variables: preoperative ureteral stents, postoperative wound left open, intraoperative fecal contamination, intraoperative ureteral injury, perioperative glucose levels, preoperative and intraoperative antibiotic administration, epidural catheter utilization, intraoperative transfusion, and operative duration. The c-statistic for the model was 0.71, and the Hesmer and Lemeshow P value was 0.648.
Once the propensity score was derived, it was used to match patients (one patient receiving preoperative oral nonabsorbable antibiotics and one patient not receiving them at the time of bowel preparation). In short, these patients were matched based on their probability score of receiving an oral antibiotic prior to elective colon surgery. We used the SAS Greedy Matching algorithm to do the case matching yielding a case-controlled subset of the data. To test the success of the matching, we compared preoperative and intraoperative factors using a 2 exact analysis to determine whether there were statistical differences between the bowel preps with and without an antibiotic before and after the propensity matching ( Table 1 ). The propensity matching was deemed successful if there was no longer any statistical difference among the clinical factors between the 2 groups.
Having balanced the covariates across 2 study groups, we then analyzed outcomes using this matched dataset. The outcome measures of interest included: deep incisional surgical site infection, organ space infection, superficial incisional surgical site infection, C. difficile colitis, and prolonged ileus. A prolonged ileus was defined as an ileus lasting greater than 7 days from the index operation. The remainder of these outcome measures are defined by the ACS-NSQIP. 27 The exact 2 test was also used to test for differences in outcomes between the 2 groups using our adjusted (matched) dataset. Except for the SAS (v9.1) matching algorithm, all analyses were performed with SPSS v17.0.
RESULTS
In Michigan 85.7% of patients received a mechanical bowel prep prior to elective colon surgery, 49.3% of patients received a mechanical bowel prep alone, whereas 36.4% of patients received mechanical bowel prep along with oral nonabsorbable antibiotics; 11.3% of patients received no bowel preparation and in 3.0% of cases bowel preparation data was not available. (Fig. 1 ) An unadjusted analysis of nonemergent cases showed that the surgical site infection (SSI) rates among patients who did and did not receive any bowel prep was not significantly different (no bowel prep 10.6% vs. bowel prep 8.2%, P ϭ 0.15). Among 15 cases that reported fecal contamination, the SSI rate was 63.6% in the 11 patients who did not receive oral antibiotics and 0% in the 4 cases that did receive oral antibiotics (P ϭ 0.051).
After excluding the 195 patients who did not receive any bowel preparation, the study group that remained included 1553 patients who received a bowel preparation. Among these patients, 38.5% received only a Fleet Enema prior to elective colon surgery, 20.9% of patients received polyethylene glycol, 5.9% of patients received Phospho soda, 5% patients received magnesium citrate, and 29.7% of patients received another type of oral bowel preparation ( Fig. 2 ). Among patients who received nonabsorbable oral antibiotics, the following types of antibiotics were administered: neomycin and erythromycin 76.3%, neomycin alone 7.9%, erythromycin alone 2.6%, metronidazole alone 2.6%, clindamycin alone 2.6%, and other antibiotic 7.9%.
On comparing the 2 study groups (no oral antibiotic N ϭ 915 and oral antibiotic at the time of bowel preparation N ϭ 638), significant differences were noted among clinical and demographic characteristics. For example, the group that received no oral antibiotics was significantly more likely to be African-American, female, take steroids, and have preoperative weight loss, diabetes, and sepsis. Further, this group had a lower BMI, have a lower case complexity, had a shorter operative duration, as well as differences in preoperative laboratory values ( Table 1 , unmatched cases). After propensity matching, there were 370 cases remaining in each group. In these matched cases, there were no statistically significant differences between the demographic and clinical characteristics of the 2 groups (Table 1, matched cases). Other important clinical characteristics that were not noted to be significantly correlated with receiving preoperative oral antibiotics included: cancer diagnosis, abdominal wound left open at the time of index operation, perioperative parenteral antibiotic administration, and rates of laparoscopic colectomy. Similarly, prophylactic antibiotics given 1 hour before incision, intraoperative antibiotic redosing, and maintenance of normothermia were not statistically different between the unmatched and matched study groups. In the unmatched sample, the prophylactic antibiotic 1 hour rates were 92.6% and 93.8% (P ϭ 0.211); the redose rate were 3.0% and 2.7% (P ϭ 0.474); and the 36°C normothermia rates were 96.1% and 96.4% (P ϭ 0.436). In the matched sample, the prophylactic antibiotic 1 hours rates were 95.0% and 96.5% (P ϭ 0.201); the redose rate were 2.2% and 1.6% (P ϭ 0.497); and the 36°C normothermia rates were 94.6% and 96.3% (P ϭ 0.184).
Using the propensity matched cohort, we then compared the incidence of surgical site infections between the 2 study groups. The group that received oral nonabsorbable antibiotics had significantly lower rates of superficial surgical site infection (2.4% vs. 8.6%, P Ͻ 0.001), organ space infections (1.6% vs. 4.3%, P ϭ 0.049), and overall SSI (4.6% vs. 12.4%, P Ͻ 0.001). (Figs. 3, 4) There was no significant difference in the rate of deep incisional surgical site infections (0.80% vs. 0.50%, P ϭ 0.69). Further, the study group that received oral antibiotics had a lower rate of prolonged ileus, (3.8% vs. 8.9%, P ϭ 0.006). No significant difference in rates of C. difficile colitis were noted between the 2 groups (1.9% vs. 3.0%, P ϭ 0.24).
DISCUSSION
More than 250,000 Americans undergo colectomy each year, and SSI rates following colectomy remain greater than 10%. [27] [28] [29] [30] Efforts to optimize the preoperative preparation of patients prior to elective colectomy are critical. In this manuscript, we describe an effort to understand more deeply the practice of elective, standard colectomy in Michigan. We noted a strong association between the administration of oral nonabsorbable antibiotics and low surgical site infection rates. We also noted that oral nonabsorbable antibiotics were associated with lower rates of prolonged ileus, and did not seem to be associated with increased rates of C. difficile colitis.
The debate regarding optimal preparation of the patient for elective colon surgery spans numerous surgical generations. The first reports of bowel preparation prior to intestinal surgery appeared in the early 1950s. Following the seminal work of Nichols, Condon, and Polk, mechanical bowel preparation with the addition of oral nonabsorbable antibiotics became standard of care prior to elective colon surgery 1-5,16 -18 More recently, well-designed clinical trials have questioned the need for any kind of mechanical bowel preparation. 6,8 -13,21 Investigators have suggested that mechanical bowel preparation may be associated with increased rates of anastomotic leak, bacterial translocation, and electrolyte disturbances. 10, 11 In addition, patients dislike the preoperative bowel preparation. 10, 13 As a result, current literature advises that preoperative mechanical bowel preparation is unnecessary. 6,8 -10,12 We used the data collection infrastructure of the MSQC to get a new perspective on the need for bowel preparation prior to colonic surgery. Here we make a distinction between treatment "efficacy," meaning what is shown to be useful within the academic confines of a RCT, and "effectiveness," meaning what actually works in a real world environment. The MSQC, consisting of 34 mostly community-based hospitals in Michigan, provides insight about the latter. We found that, despite recent admonitions from the literature, almost 90% of surgeons in Michigan regularly prescribe a bowel preparation of some kind prior to colon surgery. When we looked deeper into the type of bowel prep used, we were surprised to learn that many surgeons had stopped adding oral antibiotics to the bowel prep regimen. Certainly there is no literature which would direct this change in practice. Possibly, factors such as patient dislike for the side effects of oral antibiotics or a concern about predisposition to C. difficile colitis infection could have influenced surgeons to stop using the traditional Nichols (mechanical prep with oral antibiotics) prep. Whatever the reason, this evolving change in practice presented us with 2 large groups of roughly equal size to study the importance of oral antibiotics.
To study the 2 groups, we used a statistical approach known as propensity matching. This approach attempts to mitigate the selection bias that often plagues observational studies. Propensity matching allows for the creation of groups that are closely matched for all the important and known variables which could influence . Surgical site infection rates among propensity matched cohorts of patients who either did or did not receive oral nonabsorbable antibiotics at the time of mechanical bowel preparation prior to elective colon surgery. Patients that received oral antibiotics were observed to have significantly lower rates of prolonged ileus and overall surgical site infection. Importantly, patient to receive oral antibiotics did not have significantly higher rates of C. difficile colitis.
outcomes in colon surgery, except for the variable in question: oral antibiotics as part of the bowel prep. We further strengthened our study by prospectively defining and measuring variables which are usually not a part of studies of this type, including; the presence of ureteral stents, the occurrence of gross fecal spillage during surgery, whether or not a ureteral injury occurred, whether or not an epidural catheter was used, whether or not blood transfusions were administered during surgery, the duration of the operation itself, perioperative glucose levels, and whether or not the wound was left open at the completion of the procedure. This was possible because prior to the study, the MSQC defined and added these variables to the standard ACS-NSQIP data set, and made them a routine part of the data collection process. We believe that including important variables of this type strengthens the conclusions reached from the propensity matching approach.
It is intuitive that a mechanical bowel preparation with oral nonabsorbable antibiotics may reduce infectious complications following colon surgery. A mechanical bowel preparation alone does not reduce mucosa-associated flora. 31 Conversely, a combination of oral nonabsorbable antibiotics and intravenous antibiotics provides the greatest mucosa associated reduction in colony-forming units (1.8 ϫ 10 2 compared with 3.4 ϫ 10 7 ). 31 Previous work has indicated the importance of both oral and intravenous antibiotics prior to elective colon surgery. [32] [33] [34] Lewis, using an RCT design, evaluated the importance of oral metronidazole and neomycin as an addition to mechanical bowel preparation. 14 In this study, the single most important determinant of postoperative wound infection was the presence of bacterial growth from the subcutaneous fat at the completion of the case. Patients having received oral antibiotics demonstrated one-half the incidence of positive fat cultures when compared with those not having received oral antibiotics, and the former experienced significantly fewer wound infections as well, suggesting a cause and effect relationship. 14 Although no such measurement was done in this observational study, we did carefully identify cases in which gross spillage of residual stool had occurred during the course of surgery. In these cases, there were fewer postoperative infections if the patients had received oral antibiotics as a part of the bowel prep. We suggest that this is because the bacterial load of the spilled material was significantly reduced when the patient had been treated with oral antibiotics. Along these same lines we noted a significantly reduced incidence of intra-abdominal abscess in patients treated with oral antibiotics. Again, it seems logical to conclude that some small amount of fecal spillage during anastomosis, which could evolve into an intra-abdominal abscess, was less likely to do so if the patient had been treated with oral antibiotics as part of the bowel preparation.
Our study is not a randomized trial, but we believe there is an important role for carefully done observational studies, which provide insight into "what actually works" in a community hospital setting as well. A RCT remains the benchmark for efficacy studies for reasons familiar to all, but the design of the trial itself may lead to conclusions which are not exactly applicable to the local hospital setting. An RCT, for example, might be carried out in hospitals with a strong academic interest involving trainees, or larger more financially viable hospitals, or hospitals primarily located in affluent/poor environments, with relatively well/sick study subjects. These and many other factors could conceivably influence results. Our point is not that the RCT process is flawed, but only that results from the RCT should be complemented with observational studies, which we believe should be propensity matched, and which take place in a variety of hospital types and patient environments. This approach then provides for a different and possibly more representative population base on which to draw conclusions. The observational approach also takes into account practical problems associated with implementation. The most significant and effective antibiotic, identified as such during the course of an RCT, may not be effective if patients do not like its taste, and wont reliably follow the physicians prescription. The collective information, including conclusions about efficacy, can then be blended with conclusions about effectiveness, to get a more complete view of the importance of any given intervention. In the specific case involving the importance of oral antibiotics, there have been several RCTs supporting the importance of oral antibiotics as part of the bowel prep in reducing post colectomy infectious complications, and we now provide a large community based observational study which supports these conclusions. 3,14 -16,32 There are important limitations of this work. Because of the observational nature of this study, we are unable to attribute causality between the administration of oral nonabsorbable antibiotics and postoperative outcomes. A second important limitation is the potential for selection bias within the 2 study groups. The purpose of propensity matching is to address this bias; nonetheless the potential still exists for unmeasured confounders that could significantly influence the outcomes of this analysis. And finally, in an attempt to minimize the effect of case mix differences in our analysis, we have by design limited our study to a group of standard colectomy procedures, but not including rectal resection. How our findings might apply if rectal cases were included is not known. One might conjecture, however, that given the increased bacterial load in the rectal area, oral antibiotics might be even more effective in these circumstances. 4, 16, 18, 22 In summary, this observational study, conducted at a statewide level supports the effectiveness of adding oral antibiotics to a bowel preparation at the time of elective colectomy. The use of these antibiotics should reduce surgical site infection, prolonged ileus, and do not seem to be associated with increased risk of C. difficile colitis. Further studies must examine the efficacy of a strategy which does not include a bowel preparation at all, but when such studies are conducted they should pit the no preparation strategy itself to the gold standard existing now, which is mechanical preparation with the addition of oral antibiotics.
Discussions
DR. HIRAM POLK (LOUISVILLE, KY): This is an interesting effort to tell us what really happens in practices. I do have some concerns. I think if Dr. Englesbe and his colleagues misread history, they are certainly condemned to repeat it. I would love to see the 30-day hospital mortality rate for these large series of cases. What is the impact of systematic antibiotics? You did not point out if they were used similarly or which ones are used.
As good and simple an idea as this is, it has been very difficult to put into practice optimally.
I worry about propensity analysis and the fact that you let your individual nurse surveyors handle extra cases as time was available. How likely is it that this practice distorted the analysis toward better cases?
Finally, I remind you that these oral agents have been shown many times to be absorbable.
Finally, should you see if there are differences between your hospitals? It would be reassuring if there were not. I suspect that there are differences in outcome from hospital to hospital and death to death.
You lead us to a study we are very interested in conducting, which is that death after colon resection and complications may be the surest index of general surgery quality practice as we will ever find. Few ever die after gallbladder surgery, and the other procedures are too infrequently done. Colectomy is a high-frequency operation that has real complications and real death rates.
DR. DONALD FRY (CHICAGO, IL): I would suggest that the propensity model has enormous applicability in the current environment, where comparative effectiveness has become the new political buzzword, if not a medical buzzword. The authors' methodology can be applied to very large populations of carefully collected data to try to test the hypothesis and effectively create a virtual clinical trial.
I would amplify something that Dr. Polk mentioned, and that is that the impact of hospital variables on logistic regression of outcomes is enormous. It was the most significant variable in the hundreds of logistic models in which I have participated over the last 4 years. Did you use dummy variables for the hospitals in your equations?
You entered patient comorbidities and various treatments, but a yes/no for each of the 24 hospitals will have an enormous impact on the C statistic of the prediction value of the logistic model. If you then drop the hospital variables out, it changes the intercept. So the mathematical question is could your propensity matched intercepts have been falsely influenced by the hospital in which the patient received their care?
Finally, the independent variables that are stepped into the risk equation are always a source of debate. I would contend that the dependent variable or the actual surgical site infection rate is the most contentious issue in this analysis. Obtaining longitudinal follow-up of what happens to patients after they are released from the hospital is incredibly problematic. Since Blue Cross/Blue Shield has been a party to this, have they actually given you access to their insurance administrative data that would allow you to track these patients over time and find out who got readmitted at another hospital, who is in the emergency room having pus drained, or who is in an ambulatory care facility someplace else receiving an intervention?
The point is that unique patient identifiers in a longitudinally created data set are essential if you plan to track true outcomes.
DR. DAVID ALLISON (TOLEDO, OH): Was there a difference in experience among the surgeons in the 2 groups? Could the people who were still using antibiotics perhaps have done a bit more surgery, more colon resections than those who were not? DR. RANDY BAILEY (HOUSTON, TX): My question has to do with the choice of antibiotics. If the intravenous antibiotics used were the wrong antibiotics, we would not expect them to be very effective. Did you look specifically at which intravenous antibiotics were given? DR. MARTIN WEISER (NEW YORK, NY): Were you able to track the use of IV antibiotics? Not all studies have supported the use of oral and IV antibiotics. Could the benefit of oral antibiotics exist mainly in those patients that did not receive timely IV antibiotics? DR. MICHAEL ENGLESBE (ANN ARBOR, MI): Regarding the mortality rate, we do have data. We did not see any statistical or even clinically relevant differences in mortality rates in these elective colon patients. It is approximately 2.5% at 30 days.
I will say this: When we look at emergent colectomy, the in-hospital mortality rate in Michigan is remarkably high, particularly for patients with diabetes; upwards of 20% for emergency colectomy operations among patients with diabetes. A remarkable finding.
We specifically focused on surgical site infections. Certainly, mortality rate is a critical issue, and we are interested in colectomy because this is the most commonly performed big operation in the majority of these hospitals. Within this context, there are many opportunities to truly discern surgical quality in performing colectomies.
With respect to systemic antibiotics, we collected very specific data on intravenous antibiotics, even more granular than SCIP level data. Ninety percent of patients received some kind of SCIPcertified antibiotics.
We have not noticed big differences in outcome among different types of intravenous antibiotics.
So what does that really mean? Since most hospitals are doing a reasonably good job giving IV antibiotics within 1 hour of a surgical incision, and are generally giving the correct antibiotic, we cannot really differentiate how much that affects surgical outcomes.
To continue with Dr. Polk's questions, propensity analysis is uniquely well suited to try to create what effectively is a randomized trial. We did not necessarily collect any additional cases to do the propensity analysis. Hospitals were offered the opportunity to collect data on every colon case, and every case that was collected, we used in our propensity analysis. I certainly will take under advisement that oral nonabsorbable antibiotics are indeed not nonabsorbable. There are some good studies using Flagyl as the preoperative oral antibiotic, and it is well absorbed. Nonetheless, when Dr. Nichols and Dr. Condon wrote their initial papers, one of the criteria for a suitable antibiotic was that it had to be poorly absorbed, and that is one of the reasons they came up with Neomycin and Erythromycin. That having been said, they also counted bacterial load in the skin, as you did, Dr. Polk, and noted significantly lower rates in the skin after receiving oral antibiotics.
Finally, both Dr. Fry and Dr. Polk alluded to what I would describe as clustering. Are all of the good surgeons the ones giving the oral antibiotics, or are the good hospitals the ones giving the oral antibiotics, and is that really at the bottom of our effect? To be honest, it probably has some effect.
We are not inclined to look at surgeon specific outcomes, though the data exists. We specifically make an effort not to identify surgeons in our quality collaborative. We are not really a research operation; we are a quality operation. Surgeon-specific outcomes should be reviewed by a group of institutional peers, and such an investigation is beyond the scope of our collaborative. We leave such investigation to the surgical leadership at each institution.
With respect to variations in hospital level quality, some hospitals in our state see virtually no surgical site infections after colectomy, and they do perform primarily laparoscopic colectomy. In contrast, other hospitals have upwards of 25% surgical site infection rates.
We did not specifically adjust for hospital-level variables, simply because, even though this was a very large series, we only had 1500 cases and we had to pick our variables carefully. Nonetheless, it does not change the conclusion of our paper. It is not as eloquent a story as we did X and Y happened. We do not exactly know why we were successful, but nonetheless, we are getting our hands dirty and we are improving quality.
Dr. Fry asked about whether we really know what our SSI rates are. We use the National Surgical Quality Improvement Program, infrastructure and the nurses do collect data up to 30 days. They make a phone call at 30 days to follow-up on all cases asking patients whether they experienced a surgical site infection. So if you had your operation at hospital X but you went to the ER in hospital Y, theoretically, you would know that information. We probably have about as good data as you could get.
Yes, we have some experience with using Blue Cross and Blue Shield claims-level data. Two issues with this: First, Blue Cross and Blue Shield is kind of a silent partner. They provide funds for us to improve quality, but they do not obtain any hospitalspecific data. Our MSQC data and Blue Cross specific data (reimbursement data), are not linked. The concern among participating hospitals would be that reimbursement rates for hospitals could be affected if Blue Cross knew the granular clinical outcomes.
That having been said, I will also state that anytime you want to work with a large payer and try to use their claims data, you will be impressed with how complex it is and how difficult it is to link to clinical outcomes. In all, we have not linked MSQC data to claims data.
Dr. Allison also mentioned experienced surgeons. I think that certainly is an issue. Once again, we did not specifically control for the age of the surgeon. Are all the young surgeons causing all these complications?
Laparoscopic versus open colectomy is an excellent question. In our propensity matching, we do adjust for that. We match lap to lap, open to open. Having said that, when I suggested 4 hot-button QI items for colectomy in Michigan, one item that Dr. Campbell and I did not mention, but we definitely noticed, is a remarkably lower rate of surgical site infection in lap colons. There are probably many reasons for this. One hospital in Michigan that performs 300 or 400 a year performs almost 100% of their elective colons laparoscopically. I believe, 2 years ago, they did not see any surgical site infections, so we paid them a site visit in an effort to understand their excellent outcomes. Certainly, laparoscopic technique was one key issue in their success.
Finally, Dr. Bailey and Dr. Weiser both commented on IV antibiotics. My final comments would be that the IV antibiotic data are complex. The overall compliance was about 90%, but, the complexity was very daunting as far as what patients actually received. We are working on differentiating and describing the relationship between oral and IV antibiotics.
There is reasonable existing data, some of it 20 or 30 years old, showing that oral antibiotics in addition to IV antibiotics have the largest effect on reducing surgical site infection and reducing the bacterial load in the colon. Within that context, we will continue to recommend that patients get both.
